[en] The matrix-inserted surface transplantation model is an in vivo assay used to analyse the kinetics of tumor-vessel interactions during different stages of skin carcinoma progression. This system allows the study of host-tumor interface, i.e. penetration of tumor cells into normal host tissue as well as infiltration of normal host cells into the tumor. In the present study, image analysis algorithms for processing and quantifying the extent of such migratory and tissue remodeling events are presented. The proposed method is non-parametric and its originality lies in its particularity to take into account the specific geometry of tumor-host interface. This methodology is validated by evaluating the contribution of matrix metalloproteases (MMPs) in skin carcinoma invasion and vascularization through pharmacological and genetic approaches.
Research center :
Giga-Cancer - ULiège
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Blacher, Silvia ; Université de Liège - ULiège > Département des sciences cliniques > Labo de biologie des tumeurs et du développement
Jost, M.
Melen-Lamalle, Laurence ; Université de Liège - ULiège > Département des sciences cliniques > Labo de biologie des tumeurs et du développement
Lund, L. R.
Romer, J.
Foidart, Jean-Michel ; Université de Liège - ULiège > Département des sciences cliniques > Gynécologie - Obstétrique
Noël, Agnès ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biologie cellulaire et moléculaire appliquée à l'homme
Language :
English
Title :
Quantification of in Vivo Tumor Invasion and Vascularization by Computerized Image Analysis
Andarawewa K.L., Motrescu E.R., Chenard M.P., Gansmuller A., Stoll I., Tomasetto C., and Rio M.C. Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front. Cancer Res. 65 (2005) 10862-10871
Bajou K., Noel A., Gerard R.D., Masson V., Brunner N., Holst-Hansen C., Skobe M., Fusenig N.E., Carmeliet P., Collen D., and Foidart J.M. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat. Med. 4 (1998) 923-928
Bajou K., Masson V., Gerard R.D., Schmitt P.M., Albert V., Praus M., Lund L.R., Frandsen T.L., Brunner N., Dano K., Fusenig N.E., Weidle U., Carmeliet G., Loskutoff D., Collen D., Carmeliet P., Foidart J.M., and Noel A.S. The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin: implications for antiangiogenic strategies. J. Cell Biol. 152 (2001) 777-784
Bajou K., Maillard C., Jost M., Lijnen R.H., Gils A., Declerck P., Carmeliet P., Foidart J.M., and Noel A. Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth. Oncogene 23 (2004) 6986-6990
Cauwe B., Van den Steen P.E., and Opdenakker G. The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit. Rev. Biochem. Mol. Biol. 42 (2007) 113-185
Coussens L.M., and Werb Z. Inflammatory cells and cancer: think different!. J. Exp. Med. 193 (2001) F23-F26
Egeblad M., and Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev., Cancer 2 (2002) 161-174
Fusenig N.E., Amer S.N., Boukamp P., and Worst P.K. Characteristics of chemically transformed mouse epidermal cells in vitro and in vivo. Bull. Cancer 65 (1978) 271-279
Grobelny D., Poncz L., and Galardy R.E. Inhibition of human skin fibroblast collagenase, thermolysin, and Pseudomonas aeruginosa elastase by peptide hydroxamic acids. Biochemistry 31 (1992) 7152-7154
Handsley M.M., and Edwards D.R. Metalloproteinases and their inhibitors in tumor angiogenesis. Int. J. Cancer 115 (2005) 849-860
Jost M., Folgueras A.R., Frerart F., Pendas A.M., Blacher S., Houard X., Berndt S., Munaut C., Cataldo D., Alvarez J., Melen-Lamalle L., Foidart J.M., Lopez-Otin C., and Noel A. Earlier onset of tumoral anglogenesis in matrix metalloproteinase-19-deficient mice. Cancer Res. 66 (2006) 5234-5241
Kapur J.N., Sahoo P.K., and Wong A.K.C. A new method for gray-level picture thresholding using the entropy of the histogram. Comput. Vis. Graph. Image Process. 29 (1985)
Kohler R. A segmentation system based on thresholding. Comput. Graph. Image Process. 15 (1981) 319-338
Kuperwasser C., Chavarria T., Wu M., Magrane G., Gray J.W., Carey L., Richardson A., and Weinberg R.A. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 4966-4971
Liu K., Wahlberg P., Leonardsson G., Hagglund A.C., Ny A., Boden I., Wibom C., Lund L.R., and Ny T. Successful ovulation in plasminogen-deficient mice treated with the broad-spectrum matrix metalloproteinase inhibitor galardin. Dev. Biol. 295 (2006) 615-622
Lopez-Otin C., and Overall C.M. Protease degradomics: a new challenge for proteomics. Nat. Rev., Mol. Cell Biol. 3 (2002) 509-519
Lund L.R., Romer J., Bugge T.H., Nielsen B.S., Frandsen T.L., Degen J.L., Stephens R.W., and Dano K. Functional overlap between two classes of matrix-degrading proteases in wound healing. EMBO J. 18 (1999) 4645-4656
Lund L.R., Green K.A., Stoop A.A., Ploug M., Almholt K., Lilla J., Nielsen B.S., Christensen I.J., Craik C.S., Werb Z., Dano K., and Romer J. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice. EMBO J. 25 (2006) 2686-2697
Maillard C., Jost M., Romer M.U., Brunner N., Houard X., Lejeune A., Munaut C., Bajou K., Melen L., Dano K., Carmeliet P., Fusenig N.E., Foidart J.M., and Noel A. Host plasminogen activator inhibitor-1 promotes human skin carcinoma progression in a stage-dependent manner. Neoplasia 7 (2005) 57-66
Masson V., de la Ballina L.R., Munaut C., Wielockx B., Jost M., Maillard C., Blacher S., Bajou K., Itoh T., Itohara S., Werb Z., Libert C., Foidart J.M., and Noel A. Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes. FASEB J. 18 (2004) 234-236
Mueller M.M., and Fusenig N.E. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat. Rev., Cancer 4 (2004) 839-849
Noel A., Emonard H., Polette M., Birembaut P., and Foidart J.M. Role of matrix, fibroblasts and type-IV collagenases in tumor progression and invasion. Pathol. Res. Pract. 190 (1994) 934-941
Noel A., Hajitou A., L'Hoir C., Maquoi E., Baramova E., Lewalle J.M., Remacle A., Kebers F., Brown P., Calberg-Bacq C.M., and Foidart J.M. Inhibition of stromal matrix metalloproteases: effects on breast-tumor promotion by fibroblasts. Int. J. Cancer 76 (1998) 267-273
Noel, A., Jost, M., Maquoi, E., in press. Matrix metalloproteinases at cancer tumor-host interface. Semin. Cell Dev. Biol. doi:10.1016/j.semcdb.2007.05.01.
Overall C.M., and Dean R.A. Degradomics: systems biology of the protease web. Pleiotropic roles of MMPs in cancer. Cancer Metastasis Rev. 25 (2006) 69-75
Overall C.M., and Kleifeld O. Tumour microenvironment - Opinion - validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat. Rev., Cancer 6 (2006) 227-239
Pendas A.M., Folgueras A.R., Llano E., Caterina J., Frerard F., Rodriguez F., Astudillo A., Noel A., Birkedal-Hansen H., and Lopez-Otin C. Diet-induced obesity and reduced skin cancer susceptibility in matrix metalloproteinase 19-deficient mice. Mol. Cell. Biol. 24 (2004) 5304-5313
Soille P. Morphological Image Analysis: Principles and Applications (1999), Springer-Verlag, Berlin
Solberg H., Rinkenberger J., Dano K., Werb Z., and Lund L.R. A functional overlap of plasminogen and MMPs regulates vascularization during placental development. Development 130 (2003) 4439-4450
Zhang W.Y., Matrisian L.M., Holmbeck K., Vick C.C., and Rosenthal E.L. Fibroblast-derived MT1-MMP promotes tumor progression in vitro and in vivo. BMC Cancer 6 (2006)